These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10601557

  • 1. Comparison of action of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in human breast cancer cells.
    Oldham EA, Li C, Ke S, Wallace S, Huang P.
    Int J Oncol; 2000 Jan; 16(1):125-32. PubMed ID: 10601557
    [Abstract] [Full Text] [Related]

  • 2. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.
    Li C, Yu DF, Newman RA, Cabral F, Stephens LC, Hunter N, Milas L, Wallace S.
    Cancer Res; 1998 Jun 01; 58(11):2404-9. PubMed ID: 9622081
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
    Li C, Price JE, Milas L, Hunter NR, Ke S, Yu DF, Charnsangavej C, Wallace S.
    Clin Cancer Res; 1999 Apr 01; 5(4):891-7. PubMed ID: 10213226
    [Abstract] [Full Text] [Related]

  • 4. Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy.
    Li C, Ke S, Wu QP, Tansey W, Hunter N, Buchmiller LM, Milas L, Charnsangavej C, Wallace S.
    Clin Cancer Res; 2000 Jul 01; 6(7):2829-34. PubMed ID: 10914731
    [Abstract] [Full Text] [Related]

  • 5. Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor.
    Li C, Newman RA, Wu QP, Ke S, Chen W, Hutto T, Kan Z, Brannan MD, Charnsangavej C, Wallace S.
    Cancer Chemother Pharmacol; 2000 Jul 01; 46(5):416-22. PubMed ID: 11127947
    [Abstract] [Full Text] [Related]

  • 6. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S.
    J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel and water-soluble poly (L-glutamic acid)-paclitaxel, induce direct chromosomal abnormalities and cell death in a murine metastatic melanoma cell line.
    Multani AS, Li C, Ozen M, Yadav M, Yu DF, Wallace S, Pathak S.
    Anticancer Res; 1997 May 15; 17(6D):4269-74. PubMed ID: 9494519
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S, Mese H, Sasaki A, Yoshioka N, Matsumura T.
    Cancer Chemother Pharmacol; 2003 Jun 15; 51(6):505-11. PubMed ID: 12709826
    [Abstract] [Full Text] [Related]

  • 9. Differential gene expression profiles in paclitaxel-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells.
    Wang J, He FT, Tzang CH, Fong WF, Xiao PG, Han R, Yang MS.
    Yao Xue Xue Bao; 2005 Dec 15; 40(12):1099-104. PubMed ID: 16496673
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
    Zou Y, Fu H, Ghosh S, Farquhar D, Klostergaard J.
    Clin Cancer Res; 2004 Nov 01; 10(21):7382-91. PubMed ID: 15534115
    [Abstract] [Full Text] [Related]

  • 11. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.
    Whang YM, Park KH, Jung HY, Jo UH, Kim YH.
    Cancer; 2009 Mar 15; 115(6):1253-66. PubMed ID: 19156899
    [Abstract] [Full Text] [Related]

  • 12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 13. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
    Tanabe K, Kim R, Inoue H, Emi M, Uchida Y, Toge T.
    Int J Oncol; 2003 Apr 15; 22(4):875-81. PubMed ID: 12632082
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms.
    Yu D, Liu B, Tan M, Li J, Wang SS, Hung MC.
    Oncogene; 1996 Sep 19; 13(6):1359-65. PubMed ID: 8808711
    [Abstract] [Full Text] [Related]

  • 15. Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells.
    Ling YH, Zou Y, Perez-Soler R.
    Anticancer Res; 2000 Sep 19; 20(2A):693-702. PubMed ID: 10810342
    [Abstract] [Full Text] [Related]

  • 16. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R, Tanabe K, Emi M, Uchida Y, Osaki A, Toge T.
    Int J Oncol; 2005 Apr 19; 26(4):1025-31. PubMed ID: 15753998
    [Abstract] [Full Text] [Related]

  • 17. [Combined effects of toremifene and paclitaxel on human breast cancer cell lines].
    Maruyama S, Kuroiwa S, Saimoto A, Nishikawa K.
    Gan To Kagaku Ryoho; 2003 May 19; 30(5):669-75. PubMed ID: 12795099
    [Abstract] [Full Text] [Related]

  • 18. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
    Chen S, Gao J, Halicka HD, Huang X, Traganos F, Darzynkiewicz Z.
    Int J Oncol; 2005 Mar 19; 26(3):579-88. PubMed ID: 15703811
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of paclitaxel (taxol) analogues on MDR-positive human cancer cells.
    Distefano M, Scambia G, Ferlini C, Gallo D, De Vincenzo R, Filippini P, Riva A, Bombardelli E, Mancuso S.
    Anticancer Drug Des; 1998 Jul 19; 13(5):489-99. PubMed ID: 9702212
    [Abstract] [Full Text] [Related]

  • 20. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
    Ho TF, Peng YT, Chuang SM, Lin SC, Feng BL, Lu CH, Yu WJ, Chang JS, Chang CC.
    Toxicol Appl Pharmacol; 2009 Mar 01; 235(2):253-60. PubMed ID: 19133282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.